Darin Y. Furgeson

1.9k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Darin Y. Furgeson is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Darin Y. Furgeson has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Cell Biology. Recurrent topics in Darin Y. Furgeson's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Virus-based gene therapy research (4 papers). Darin Y. Furgeson is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Virus-based gene therapy research (4 papers). Darin Y. Furgeson collaborates with scholars based in United States and South Korea. Darin Y. Furgeson's co-authors include Valerie Fako, Ralph M. Albrecht, Ashutosh Chilkoti, Matthew R. Dreher, Sung Wan Kim, James W. Yockman, Younsoo Bae, Pilju Youn, Ram I. Mahato and Hong Yuan and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Small.

In The Last Decade

Darin Y. Furgeson

17 papers receiving 1.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos

2009 513 citations Ralph M. Albrecht, Valerie Fako et al. Small profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darin Y. Furgeson United States	15	582	561	379	305	270	17	1.5k
Yiling Hong United States	24	1.3k 2.2×	996 1.8×	153 0.4×	539 1.8×	85 0.3×	46	2.7k
Yangzhouyun Xie China	19	949 1.6×	761 1.4×	193 0.5×	618 2.0×	119 0.4×	26	2.0k
Natalia V. Dolgova United States	25	450 0.8×	251 0.4×	173 0.5×	293 1.0×	71 0.3×	61	1.7k
Christopher G. Thanos United States	16	431 0.7×	282 0.5×	311 0.8×	343 1.1×	40 0.1×	23	1.3k
Michal Babič Czechia	20	409 0.7×	496 0.9×	737 1.9×	787 2.6×	46 0.2×	47	1.8k
Rong Zhou China	21	714 1.2×	435 0.8×	747 2.0×	354 1.2×	50 0.2×	57	1.8k
Carolin Bier Germany	16	804 1.4×	270 0.5×	469 1.2×	259 0.8×	32 0.1×	23	1.4k
Daniela Maggioni Italy	22	812 1.4×	450 0.8×	68 0.2×	102 0.3×	619 2.3×	39	2.1k
Yujie Zhu China	21	418 0.7×	167 0.3×	314 0.8×	791 2.6×	59 0.2×	35	1.4k

Countries citing papers authored by Darin Y. Furgeson

Since Specialization

Citations

This map shows the geographic impact of Darin Y. Furgeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darin Y. Furgeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darin Y. Furgeson more than expected).

Fields of papers citing papers by Darin Y. Furgeson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darin Y. Furgeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darin Y. Furgeson. The network helps show where Darin Y. Furgeson may publish in the future.

Co-authorship network of co-authors of Darin Y. Furgeson

This figure shows the co-authorship network connecting the top 25 collaborators of Darin Y. Furgeson. A scholar is included among the top collaborators of Darin Y. Furgeson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darin Y. Furgeson. Darin Y. Furgeson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Youn, Pilju, et al.. (2015). Cytoprotection against beta-amyloid (Aβ) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells. Neuroscience Research. 94. 70–78. 7 indexed citations

Youn, Pilju, et al.. (2014). Tumour eradication using synchronous thermal ablation and Hsp90 chemotherapy with protein engineered triblock biopolymer-geldanamycin conjugates. International Journal of Hyperthermia. 30(8). 550–564. 8 indexed citations

Youn, Pilju, et al.. (2014). A Myristoylated Cell-Penetrating Peptide Bearing a Transferrin Receptor-Targeting Sequence for Neuro-Targeted siRNA Delivery. Molecular Pharmaceutics. 11(2). 486–495. 60 indexed citations

Bohnsack, John, Shoeleh Assemi, Jan D. Miller, & Darin Y. Furgeson. (2012). The Primacy of Physicochemical Characterization of Nanomaterials for Reliable Toxicity Assessment: A Review of the Zebrafish Nanotoxicology Model. Methods in molecular biology. 926. 261–316. 20 indexed citations

Bae, Younsoo, et al.. (2011). Biodegradable hybrid recombinant block copolymers for non-viral gene transfection. International Journal of Pharmaceutics. 427(1). 105–112. 14 indexed citations

Albrecht, Ralph M., et al.. (2009). Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos. Small. 5(16). 1897–1910. 513 indexed citations breakdown →

Fako, Valerie & Darin Y. Furgeson. (2009). Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Advanced Drug Delivery Reviews. 61(6). 478–486. 218 indexed citations

Bae, Younsoo, et al.. (2007). Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of HSP90 inhibitor geldanamycin. Journal of Controlled Release. 122(1). 16–23. 26 indexed citations

Bae, Younsoo, et al.. (2007). Intelligent Biosynthetic Nanobiomaterials (IBNs) for Hyperthermic Gene Delivery. Pharmaceutical Research. 25(3). 683–691. 66 indexed citations

10.

Liu, Wenge, Matthew R. Dreher, Darin Y. Furgeson, et al.. (2006). Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. Journal of Controlled Release. 116(2). 170–178. 126 indexed citations

11.

Furgeson, Darin Y., Matthew R. Dreher, & Ashutosh Chilkoti. (2005). Structural optimization of a “smart” doxorubicin–polypeptide conjugate for thermally targeted delivery to solid tumors. Journal of Controlled Release. 110(2). 362–369. 144 indexed citations

12.

Janát‐Amsbury, Margit M., James W. Yockman, Minhyung Lee, et al.. (2004). Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Molecular Therapy. 9(6). 829–836. 74 indexed citations

13.

Furgeson, Darin Y., et al.. (2004). Tumor Efficacy and Biodistribution of Linear Polyethylenimine-cholesterol/DNA Complexes. Molecular Therapy. 9(6). 837–845. 23 indexed citations

14.

Janát‐Amsbury, Margit M., James W. Yockman, Minhyung Lee, et al.. (2004). Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. Journal of Controlled Release. 101(1-3). 273–285. 16 indexed citations

15.

Furgeson, Darin Y., et al.. (2003). Modified Linear Polyethylenimine−Cholesterol Conjugates for DNA Complexation. Bioconjugate Chemistry. 14(4). 840–847. 62 indexed citations

16.

Furgeson, Darin Y., et al.. (2002). Novel Water Insoluble Lipoparticulates for Gene Delivery. Pharmaceutical Research. 19(4). 382–390. 26 indexed citations

17.

Maheshwari, Anurag, et al.. (2001). Folate-PEG-Folate-Graft-Polyethylenimine-Based Gene Delivery. Journal of drug targeting. 9(2). 123–139. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact